Patient Timeline (as described)
| Time from Implant | Event | Notes |
|---|---|---|
| 0 months (May 2024) | Single‑chamber leadless pacemaker (LP) placement | Baseline capture adequate |
| ~11 months | Nocturnal non‑capture appears | Output increased 1.25 V → 3.0 V |
| ~14 months | Nocturnal non‑capture recurs | Despite prior output increase |
| 18 months | Nocturnal non‑capture disappears | No new intervention or output change |
Most plausible mechanisms
1) Electrode–myocardium interface dynamics
- Fibrotic healing and encapsulation can elevate capture thresholds around 6–12 months post‑implant.
- Late stabilization/remodeling (12–18 months) may lower thresholds again, explaining spontaneous resolution.
- Micro‑motion (micro‑dislodgement) early on may later “settle” as encapsulation matures.
2) Circadian/autonomic effects
- During sleep, vagal tone rises and myocardial excitability may drop, transiently increasing thresholds (nocturnal pattern).
- Night‑specific factors (sleep apnea, hypoxia, thoracic pressure swings) can intermittently impair capture.
- Subsequent improvement in sleep‑disordered breathing or autonomic balance can normalize nocturnal capture without reprogramming.
3) Device & algorithm behavior
- Raising output to 3.0 V can mask but not eliminate nocturnal threshold surges.
- Some LPs adapt sensing/pacing margins over time; algorithmic adaptation may contribute to late recovery.
4) Myocardial substrate & systemic factors
- Transient myocarditis/ischemia, electrolyte shifts, or medication changes can raise thresholds and later resolve.
- Training/detraining, weight change, or improved control of comorbidities (HF, CKD, DM) can modulate thresholds.
5) Apparent vs. true non‑capture
- Nocturnal fusion/pseudofusion or sensing anomalies may mimic non‑capture; stability later reduces misclassification.
Why the specific pattern makes sense
The sequence — appearance at ~11 months, recurrence at ~14 months despite higher output, and spontaneous disappearance by 18 months — is most consistent with a temporary threshold rise from interface fibrosis plus nocturnal autonomic effects, followed by late stabilization of the electrode–tissue interface. This natural history has been reported clinically in many LP/CIED contexts.
Suggested evaluation plan (practical)
- Trend capture thresholds day vs. night; consider an overnight threshold test if device supports it.
- Screen for sleep‑disordered breathing (home sleep study if indicated).
- Review electrolytes, medication changes (e.g., antiarrhythmics), and intercurrent illnesses.
- Check for pseudofusion/fusion via stored electrograms or ambulatory ECG correlation.
- Maintain a reasonable safety margin (voltage/pulse width) while avoiding undue battery drain.